Get the latest tech news
New drug extends lifespan by 25%, fights aging, could prevent cancer | Researchers administered an injection of an anti-IL-11 antibody to 75-week-old mice, neutralizing the harmful effects of IL-11.
This study opens new possibilities for anti-aging therapies and highlights the potential of IL-11 suppression for longevity.
According to the study published in the journal Nature, the new results “suggest that those potential treatments might also have an impact on longevity, but separate clinical trials are needed to be certain.” Still, IL-11’s clear path to testing in humans distinguishes it from the crowd of other proteins and rejuvenation interventions, many of which have shown promise in animal models but stalled on the way to clinical trials. Researchers have been studying the role of IL-11 for quite some time, but they were not sure how the protein and aging were connected until molecular biologist Anissa Widjaja discovered it by accident.
Or read this on r/tech
